VAERS reports by lot

GSK Varicella/Shingles lot 27PA5: VAERS reports

65 VAERS reports list lot 27PA5 as a GSK Varicella/Shingles vaccine, received between 2021-07-17 and 2024-05-16. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
65
Reports
0%
Marked serious
0
With a death outcome
11
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction1436%
General / Systemic (non-local)1231%
Neurological410%
Musculoskeletal410%
Gastrointestinal25%
Autoimmune / Immune-mediated13%
Respiratory13%
Psychiatric / Neuropsychiatric13%

Where reports came from

U.S. state of the reporter, where given (top 12).

District of Columbia33
Florida3
Illinois2
Texas2
Kansas2
Indiana2
Pennsylvania1
California1
New York1
Virginia1
Oklahoma1
Kentucky1

Reports by month received

2021-074
2021-084
2021-093
2021-104
2021-112
2022-071
2023-1215
2024-0114
2024-0211
2024-032
2024-055

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.